Study drug for advanced melanoma and other solid tumors
Part of Cancer, Eyes & vision, Skin clinical trials.
This Phase 1 trial studies a new experimental immunotherapy (MBS8) for people with advanced solid tumors, focusing first on safety and early signs of benefit. Depending on your cancer type and past treatments, you may receive MBS8 alone or combined with pembrolizumab.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have an advanced solid tumor that has grown or progressed, with no standard options or you chose not to get standard treatment.
- A cancer spot is available so doctors can take tumor samples (biopsies) more than once.
- You can come to scheduled visits and blood tests, and you can have the required biopsies (unless your doctor says it’s unsafe).
- Recent scans show measurable cancer, and your general strength is fairly good (ECOG 0–1).
- Your basic organ/blood tests are within required ranges (blood counts, kidney, liver), and you’re expected to live more than 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests a new treatment in people with advanced (locally advanced or metastatic) solid tumors that have worsened or cannot be treated with standard therapies. It may help shrink tumors or slow growth, and it also helps doctors learn the safest way to use the medicine.
This trial tests a new drug (BT02) for advanced melanoma that has stopped responding to earlier treatments. The goal is to see if it is safe and may help shrink tumors.
This trial tests an experimental drug called KM602 for people with advanced solid tumors that have stopped responding to standard treatments, particularly melanoma and non-small cell lung cancer. It aims to see if the drug is safe and effective in shrinking or controlling tumors.
This early study tests a new medicine (BPI-460372) in adults with advanced solid cancers that have come back or can’t be treated with standard options. It may help by targeting specific cancer changes in certain tumors, and doctors will also learn the safest dose.
This trial is testing a new drug called BL-M08D for people with melanoma or other solid tumors that have spread. The drug aims to attack cancer cells, and researchers want to see if it is safe and effective.
This trial tests an experimental drug called MHB046C for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it can shrink tumors or slow their growth.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.